science
plus
.abes.fr
|
explorer
À propos de :
M.Pardridge William
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
foaf:Person
, within Data Space :
scienceplus.abes.fr
associated with source
document(s)
Type:
Person
New Facet based on Instances of this Class
Attributs
Valeurs
type
Person
name
M.Pardridge William
Pardridge William M.
familyName
Pardridge
M.Pardridge
Given name
William
W. M.
William M.
is
relates
of
http://hub.abes.fr/acs/periodical/bcches/1994/volume_5/issue_2/101021bc00026a003/authorship/4
http://hub.abes.fr/acs/periodical/bcches/1994/volume_5/issue_5/101021bc00029a005/authorship/2
http://hub.abes.fr/acs/periodical/bcches/1999/volume_10/issue_3/101021bc980123x/authorship/3
http://hub.abes.fr/acs/periodical/bcches/2000/volume_11/issue_3/101021bc9901393/authorship/2
http://hub.abes.fr/oup/periodical/proeng/1999/volume_12/issue_9/101093protein129787/authorship/7
http://hub.abes.fr/oup/periodical/jid/1988/volume_158/issue_3/101093infdis1583630/authorship/2
http://hub.abes.fr/oup/periodical/jid/1994/volume_169/issue_1/101093infdis169155/authorship/1
http://hub.abes.fr/oup/periodical/jid/1994/volume_170/issue_3/101093infdis1703563/authorship/1
http://hub.abes.fr/acs/periodical/bcches/2008/volume_19/issue_3/101021bc7004076/authorship/6
http://hub.abes.fr/acs/periodical/bcches/2008/volume_19/issue_7/101021bc800148t/authorship/1
http://hub.abes.fr/acs/periodical/bcches/2007/volume_18/issue_2/101021bc060349x/authorship/5
http://hub.abes.fr/acs/periodical/bcches/2003/volume_14/issue_3/101021bc0256648/authorship/2
http://hub.abes.fr/acs/periodical/bcches/1999/volume_10/issue_1/101021bc9800522/authorship/3
http://hub.abes.fr/acs/periodical/bcches/2001/volume_12/issue_6/101021bc0155061/authorship/2
http://hub.abes.fr/acs/periodical/bichaw/1988/volume_27/issue_10/101021bi00410a015/authorship/2
http://hub.abes.fr/acs/periodical/bcches/1992/volume_3/issue_6/101021bc00018a010/authorship/2
http://hub.abes.fr/springer/periodical/11095/1994/volume_11/issue_5/B8EDE7B5E42C3075E053120B220A7CD7/authorship/1
http://hub.abes.fr/springer/periodical/11064/1990/volume_15/issue_8/B925BA8E2CAF4B2AE053120B220AE7D7/authorship/2
http://hub.abes.fr/springer/periodical/125/1981/volume_20/issue_3/B9267F136A4E5090E053120B220A1D5D/authorship/1
http://hub.abes.fr/springer/periodical/11064/1989/volume_14/issue_7/B925BA8E231E4B2AE053120B220AE7D7/authorship/2
http://hub.abes.fr/springer/periodical/11095/1994/volume_11/issue_9/B8EDE7B5E3F63075E053120B220A7CD7/authorship/2
http://hub.abes.fr/springer/periodical/11095/1995/volume_12/issue_6/B8EDE7B5E2DD3075E053120B220A7CD7/authorship/1
http://hub.abes.fr/springer/periodical/18/1973/volume_29/issue_3/B8EC5FF8FE593C0DE053120B220A0D5B/authorship/1
http://hub.abes.fr/acs/periodical/bcches/1995/volume_6/issue_2/101021bc00032a009/authorship/3
is
Author
of
Development and in vitro Characterization of a Cationized Monoclonal Antibody against βA4 Protein: A Potential Probe for Alzheimer's Disease
Differential binding of thyroxine and triiodothyronine to acidic isoforms of thyroid hormone binding globulin in human serum
Complete protection of antisense oligonucleotides against serum nuclease degradation by an avidin-biotin system
In Vivo Cleavability of a Disulfide-Based Chimeric Opioid Peptide in Rat Brain
Red cell phenylalanine is not available for transport through the blood-brain barrier
Treatment Of Human Immunodeficiency Virus-Infected Lymphocytes With Cationized Human Immunoglobulins
Pharmacokinetics and Delivery of Tat and Tat-Protein Conjugatesto Tissues in Vivo
Monoclonal Antibody Radiopharmaceuticals: Cationization,Pegylation, Radiometal Chelation, Pharmacokinetics, and TumorImaging
Genetic Engineering, Expression, and Activity of a Chimeric Monoclonal Antibody−Avidin Fusion Protein for Receptor-Mediated Delivery of Biotinylated Drugs in Humans
Retention of Biologic Activity of Human Epidermal Growth FactorFollowing Conjugation to a Blood-Brain Barrier Drug DeliveryVector via an Extended Poly(ethylene glycol) Linker
Epidermal Growth Factor Radiopharmaceuticals: 111In Chelation,Conjugation to a Blood-Brain Barrier Delivery Vector via aBiotin-Polyethylene Linker, Pharacokinetics, and in Vivo Imaging ofExperimental Brain Tumors
Restricted Transport of 3′-Azido-3′-Deoxythymidine and Dideoxynucleosides Through the Blood-Brain Barrier
Enhanced Endocytosis and Anti-Human Immunodeficiency Virus Type 1 Activity of Anti-rev Antibodies after Cationization
Genetically engineered brain drug delivery vectors: cloning, expression and in vivo application of an anti-transferrin receptor single chain antibody-streptavidin fusion gene and protein
Fusion Antibody for Alzheimer's Disease with Bidirectional Transport Across theBlood−Brain Barrier and Aβ Fibril Disaggregation
Re-Engineering Biopharmaceuticals for Delivery to Brain with Molecular Trojan Horses
Aβ1-40 Peptide Radiopharmaceuticals for Brain Amyloid Imaging: 111In Chelation, Conjugation to Poly(ethylene glycol)-Biotin Linkers,and Autoradiography with Alzheimer's Disease Brain Sections
Transport of Human Recombinant Brain-Derived Neurotrophic Factor (BDNF) Through the Rat Blood−Brain Barrier in Vivo Using Vector-Mediated Peptide Drug Delivery
Saturable transport of amphetamine across the blood-brain barrier
Transport of nutrients and hormones through the blood-brain barrier
Human Insulin Receptor Monoclonal Antibody Undergoes High Affinity Binding to Human Brain Capillaries in Vitro and Rapid Transcytosis Through the Blood-Brain Barrier in Vivo in the Primate
Brain Delivery of Biotin Bound to a Conjugate of Neutral Avidin and Cationized Human Albumin
Triiodothyronine bound to red blood cells is not available for transport through the blood-brain barrier
Complete Inactivation of Target mRNA by Biotinylated Antisense Oligodeoxynucleotide-Avidin Conjugates
Alternative Linked Data Documents:
ODE
Content Formats:
RDF
ODATA
Microdata
